Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share
Calgary, Alberta--(Newsfile Corp. - May 12, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"),...
Clinical Trial
MEDVi Under Review: Best GLP-1 Semaglutide & Terzepatide Compound Solution for Personalized Weight Loss
A Comprehensive Review of MEDVi’s Personalized GLP-1 Weight Loss Solutions Featuring Affordable Compounded Semaglutide and Tirzepatide Delivered via TelehealthNew York,...
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology response Data contribute to growing...
Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis
Late-breaking results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial presented at the EASL...
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational Phase 3 trial in addition to topline 18-month...
Anivive’s Dr. Edward Robb Presents Innovative Valley Fever Vaccine Research at World Vaccine Congress 2025
WASHINGTON, May 9, 2025 /PRNewswire/ -- Dr. Edward Robb, Chief Strategy Officer, Anivive Lifesciences presented their pioneering research update on...
SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates
MIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with...
Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
Conduit secures a composition of matter patent from the Korean Intellectual Property Office for its lead asset, AZD1656, a Glucokinase...
Ocugen Provides Business Update with First Quarter 2025 Financial Results
Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing...
Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025
DURHAM, N.C., May 09, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable,...
PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights
Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53...
Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025
SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational...
Spectral Medical Announces First Quarter and Provides Corporate Update
Tigris Trial Enrollment completedTopline results expected to be released in August 2025Entered into an up to US$10 million Promissory Note...
Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health
PURCHASE, N.Y., May 09, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing drugs that treat...
Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration
TUCSON, Ariz., May 8, 2025 /PRNewswire/ -- The year 2025 marks a historic milestone for Critical Path Institute® (C-Path), as the...
Amavita Heart and Vascular Health Achieves Two Prestigious IAOCR Certifications
MIAMI, May 8, 2025 /PRNewswire/ -- Amavita Heart and Vascular Research Services LLC the research arm of Amavita Heart and...
Reimagining the Cold Chain: Artyc PBC Introduces Medstow 5L to Power a New Era of Healthcare Logistics
Designed for hospitals, clinical trial sites, and home-care teams, the Medstow 5L Intercampus delivers precise, programmable cooling with continuous, auditable...
Al in Pathology Market worth $347.4 million by 2030 with 26.5% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., May 8, 2025 /PRNewswire/ -- The global AI in Pathology Market, valued at US$87.2 million in 2024, is...
COPILOT Appoints Era Prakash as Senior Vice President of Solutions Development
Healthcare Leader to Drive Transformational Change in Reimbursement and Patient Support HUBs MAITLAND, Fla., May 8, 2025 /PRNewswire/ -- COPILOT, a...
From Patient to Pioneer: jinIX Supports Nathan Ehrlich’s Mission for Rare Disease Research
SAN FRANCISCO, May 8, 2025 /PRNewswire/ -- The jinIX Foundation hosted a meaningful and inspiring gathering—not just to mark the launch...